A new study reveals that entacapone, a drug used to treat Parkinson’s disease, significantly disrupts the gut microbiome by ...
Building on this discovery, the team found that an existing Parkinson's disease drug can effectively alleviate nicotine withdrawal symptoms, thus increasing its potential for therapeutic use.
And some researchers hoped that the drugs could also help with some of the most difficult diseases to treat — those of the brain, like Parkinson’s. But now, at least for Parkinson’s ...
A new study reveals disappointing results on the potential of GLP-1 drugs like Ozempic to treat Parkinson's disease. Despite earlier hopes, a rigorous 96-week trial with 194 participants found no ...
After SPN-820's failure, Supernus is relying on its non-stimulant ADHD drug Qelbree and the recently approved Parkinson’s ...
WEDNESDAY, Feb. 5, 2025 (HealthDay News) -- Hopes that GLP-1 drugs such as Ozempic and Wegovy could help slow Parkinson's ...
The Tyson-Paul fight had to be re-scheduled from July 20 to Nov. 15 after Tyson had a medical emergency on a plane during the ...
The FDA on Tuesday signed off on Supernus Pharmaceuticals’ apomorphine hydrochloride injection—to be marketed under the brand name Onapgo—for use in adults with Parkinson’s disease.
Experts from Huashan Hospital conduct Parkinson's disease research in a laboratory.
The US Food and Drug Administration (FDA) rejected three prior regulatory applications before granting approval.
A breakthrough study has uncovered a hidden player in Parkinson’s disease—24-OHC, a cholesterol metabolite that fuels the ...
Mike Tyson's ulcer-related emergency delayed his fight with Jake Paul until November, as Paul claimed Tyson used psychedelics ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results